Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Quality Control Strategies for Drug Development and Manufacturing
*Corresponding Author:Received Date: Feb 01, 2024 / Published Date: Feb 29, 2024
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Quality control is a critical aspect of drug development and manufacturing, ensuring the safety, efficacy, and reliability of pharmaceutical products. This article provides an overview of key strategies employed in quality control throughout the drug development and manufacturing processes. From comprehensive analytical testing to regulatory compliance and continuous improvement, these strategies contribute to the creation of high-quality pharmaceuticals. The article emphasizes the importance of adherence to Good Manufacturing Practices (GMP), risk-based approaches, data integrity, stability testing, and personnel competence. By adopting these strategies, pharmaceutical companies can enhance product quality, meet regulatory standards, and prioritize patient well-being
